Doctors urge FDA to tighten up on opioids; Novartis restarts Excedrin production;

 @FiercePharma: The common cry from Big Pharma this quarter: Europe's dreadful. And Parallel trade makes it worse--ReutersMore | Follow @FiercePharma

> A group of doctors and public health leaders petitioned the FDA for tighter restrictions on powerful painkillers. Report

> Novartis has restarted production of Excedrin, aiming to satisfy migraine sufferers' cries for a product that's been missing from store shelves since a recall 6 months ago. Report

> India's Lupin says it's hoping to enter the market for certain inhaled asthma drugs, with its key target a knockoff version of GlaxoSmithKline's blockbuster Advair. Report

> Sanofi's Genzyme unit was ordered to pay $50 million to settle a patent dispute with the small biotech company Shelbyzyme. Report

> Johnson & Johnson's Janssen unit launched a mobile app designed to help patients stick to their drug regimens, part of pharma's ongoing struggle to boost compliance. Report

> Drug distributor AmerisourceBergen ($ABC) posted street-beating profits despite a downward tick in sales. Report

Medical Device News

 @FierceMedDev: Hill-Rom has snatched up Aspen Surgical Products for $400 million. Release | Follow @FierceMedDev

 @MarkHFierce: The fight goes on. Advamed, via Abiomed's Michael Minogue, are pushing Congress to repeal the 2.3% device tax. More | Follow @MarkHFierce

 @DamianFierce: Boston Scientific posted a $3.4B second-quarter loss, citing sluggish markets abroad. News | Follow @DamianFierce

> Covidien tops expectations on strong device sales. Article

> Bard's sales rise slightly, nicked by foreign exchange rates. Report

> Device giant Terumo seeks merger with Olympus. More

Biotech News

 @FierceBiotech: GE, iBio unite on plant-based production of vaccines and biologics. Item | Follow @FierceBiotech

 @JohnCFierce: EIU on Astra: "So far the departure of boss David Brennan in June seems to have made little difference to the gloom surrounding the company."  | Follow @JohnCFierce

 @RyanMFierce: Science journos spend lots of time translating jargon into simple terms. Nature argues against some of this practice. Article | Follow @RyanMFierce

> As sales slide AstraZeneca stays fixed on rapid-fire deal strategy. Story

> Analysts bet on likely approval, pact for Amarin blockbuster AMR101. Report

> Hyperion takes standard biotech haircut on $50M IPO. News

Pharma Manufacturing News

> FDA ravages Sanofi vaccine sterility process in warning letter. Article

> Sun Pharma standardizing manufacturing globally. Story

> California county orders drugmakers to pay for drug disposal. News

> FDA to Congress: Agency can't dodge plant problems to avoid shortages. More

Vaccines News

> FDA wags finger at Sanofi for no-nos at vaccine plants. News

> GE, iBio unite on plant-based production of vaccines and biologics. Item

> Sanofi vaccine combats most viral causes of dengue. Story

> Researchers hope to turn white blood cells into a vaccine. More

> Medicago completes rapid-fire flu vaccine production. Article

> Vaxil BioTherapeutics debuts on Tel Aviv Stock Exchange. Item

And Finally... A Merck ($MRK) cancer drug exposed hidden HIV deposits in a new study, hinting at a possible cure for the disease. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.